Federal contractor · THOROLD

NORGEN BIOTEK CORP

NORGEN BIOTEK CORP received -$75.2K in federal contract obligations in FY2026, on 3 awards (−148% vs FY2025). Since FY2017: $799.9K. Its largest customer was National Institutes of Health (-$75.2K).

Obligations · FY2026
-$75.2K
New awards
3
Sole-source
—
Single offer
—
UEI
SB5ZH66FTV27
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 41.8KFY2017
  2. 165KFY2019
  3. 0FY2020
  4. 119.2KFY2021
  5. 41.4KFY2022
  6. 350.8KFY2023
  7. 357.8FY2024
  8. 156.6KFY2025
  9. -75.2KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health-$75.2K0.0%
    3 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$44K100%

Where the work was performed

  1. Montgomery County, MD$27.2K0.0%

Integrity signals

Shares of the year's obligations, next to the country's.

Agencies awarding it sole-source contracts

  1. National Institutes of Health-$102.4K
    Department of Health and Human Services · 1 awards

Largest awards

  1. NIAAA: 1. SERVICE FOR ITEM 86000: EXOSOMAL RNA SERVICE RNA PURIFICATION FROM INTACT EXOSOMES (ALIQUOT B) ELUTED INTO 2 ALIQUOTS OF RNA (1 VIAL TO BE RETURNED TO CLIENT) (1 VIAL FOR SMALL RNA-SEQ) QC OF RNA. 2. ITEM 85960: SMALL RNA-SEQUENCING LIBR$27.2K
    National Institutes of Health· Montgomery County, MD· Health & medical· Jul 20, 2026 – Jul 20, 2026· 75N98026P01064
  2. NHGRI - EXOSOME PURIFICATION RNA ISOLATION KITS$16.8K
    National Institutes of Health· Health & medical· Aug 26, 2026 – Aug 26, 2026· 75N98026P01422
  3. THE PURPOSE OF THIS ACQUISITION IS TO PURCHASE EXOSOME EXTRACTION FOR FUTURE RNA SEQUENCING SERVICES FOR NHGRI.$0
    National Institutes of Health· Professional services· Aug 6, 2021 – May 7, 2026· 75N92021P00271

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 3 markets (agency × industry), FY2024–FY2026.

  1. PROTEOGENIX$124.2K−100% in FY2026
    SCHILTIGHEIM, FRA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Scientific research and development servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. REPROCELL U.S.A., INC.$127.6K
    BELTSVILLE, MD · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Scientific research and development servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. QPS LLC$109.5K−100% in FY2026
    NEWARK, DE · 79% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.